Addiction Treatment Outcome Monitoring Study

Not Applicable

Completed

• Conditions: Alcohol Use Disorder; Substance Use Disorders
• Interventions: Other: Measurement; Other: Feedback

• Registration Number: NCT04155385
• Lead Sponsor: University of Washington

Brief Summary

This research evaluates a tool designed for measurement-based care in addiction treatment. Patients in addiction treatment will be invited to complete weekly measures indicating treatment progress and goals. For half the patients, their addiction treatment clinician will be able to view their weekly progress and goals via a secure dashboard. The research will test the feasibility and acceptability of the measurement-based care tool and will evaluate its impact on within-session discussion topics and clinical outcome measures.

Detailed Description

Not available

Study Timeline

• Study Start: 2019-10-04
• Study First Submitted: 2019-11-01
• Study First Submitted QC: 2019-11-04
• Study First Posted: 2019-11-07
• Primary Completion: 2021-12-01
• Study Completion: 2021-12-01
• Status Verified: 2022-05
• Last Update Submitted: 2022-05-13
• Last Update Posted: 2022-05-20

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

1. At least 18 years old.
2. Self-reports that they are a patient at Harborview Mental Health and Addiction Services (HMHAS) clinic.
3. Self-reports that they are receiving services at HMHAS clinic for an alcohol or drug-related concern.
4. Has a smartphone with a working phone number and a mobile plan that allows text messages and internet connection.
5. AUDIT-C score indicates past-year hazardous drinking (summed score is at least 3 or 4 for women or men, respectively), or self-reports any drug use for non-medical reasons in the past year.
6. Does not anticipate moving away from the Seattle area within 6 months.
7. Does not anticipate becoming incarcerated in next 6 months.
8. Able to speak and read English (based on self-report).
9. Must be receiving clinical services from an HMHAS clinician who is also participating in the study, which will be evidenced by having at least 3 appointments with a participating HMHAS clinician that were either completed within the past three months or are scheduled to occur within the next three months, verified by the electronic health record.

Read More

Exclusion Criteria

• None

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Measurement and feedback	Feedback	Patients will complete weekly measures of treatment progress and goals; the information from these measures will be shared with clinicians.
Measurement and feedback	Measurement	Patients will complete weekly measures of treatment progress and goals; the information from these measures will be shared with clinicians.
Measurement-only	Measurement	Patients will complete weekly measures of treatment progress and goals; however, the information from these measures will not be shared with clinicians or patients.

Primary Outcome Measures

Name	Time	Method
Changes in treatment outcomes as measured by the weekly progress measure	6 months	Self-reported responses to the weekly progress measure will be evaluated using longitudinal growth curve models. The check-in measure was developed for the current study and consists of items drawn from several existing measures, including the Substance Use Recovery Evaluator, Alcohol Abstinence Self-Efficacy scale, Working Alliance Inventory, and Patient Health Questionnaire-2. The measure is called "The Weekly Check-In" and it provides a "total recovery score" ranging from 0 to 100, with higher scores indicating better outcomes.
Measure completion	6 months	Logged number of weekly measurement-based care surveys that were completed
Discussion of topics measured by the weekly progress measure	About 6 weeks after enrollment	Self-reported amount of time spent discussing topics measured in the weekly progress measure. This will be measured via a self-report questionnaire ("In-Session Discussion Topics" questionnaire), which was generated for the current study. The measure will assess the extent to which they discussed each of the following topics in their most recent treatment session: Drinking/drug use, cravings, coping strategies, abstinence self-efficacy, outlook on life, mental health, therapeutic alliance, and treatment goals. Each item is reported on a 4-point Likert scale (minimum value = 0 "did not discuss", maximum value = 3 "discussed extensively" -- higher scores do not necessarily indicate "better" clinical outcomes; however, we hypothesize that the measurement-based care tool will increase the in-session discussion of these topics, and therefore higher outcomes in the measurement-and-feedback group would be consistent with our hypothesis).

Secondary Outcome Measures

Name	Time	Method
Clinician log-ins to dashboard	6 months	Number of log-ins to the clinician-facing dashboard, which will be tracked automatically by the dashboard website.

Trial Locations

Locations (1)

University of Washington; 🇺🇸 Seattle, Washington, United States